TWM
BSX icon

Thrive Wealth Management’s Boston Scientific BSX Stock Holding History

Thrive Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Sell
6,950
-539
-7% -$29.3K 0.04% 195
2026
Q1 		$470K Buy
7,489
+102
+1% +$8.16K 0.07% 126
2025
Q4 		$704K Buy
7,387
+117
+2% +$11.5K 0.1% 101
2025
Q3 		$710K Sell
7,270
-54
-0.7% -$5.59K 0.11% 106
2025
Q2 		$787K Buy
+7,324
New +$741K 0.13% 95

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thrive Wealth Management's BSX Position: Q2 2026 in Review

Thrive Wealth Management reduced its Boston Scientific (BSX) stake by 7.2% in Q2 2026, selling an estimated $29.3K and leaving 6,950 shares worth $297K. The position accounts for 0.04% of the portfolio, ranked #195.

Thrive Wealth Management first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $787K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Thrive Wealth Management held 6,950 shares of Boston Scientific worth $297K as of Q2 2026.
  • Thrive Wealth Management sold 539 Boston Scientific shares in Q2 2026, an estimated $29.3K.
  • Boston Scientific made up 0.04% of Thrive Wealth Management's portfolio in Q2 2026, its #195 holding.
  • Thrive Wealth Management first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Thrive Wealth Management's Boston Scientific position peaked at $787K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.